Quintiles and Q² Solutions join senior biopharma leaders involved in oncology drug development to discuss current challenges and topical issues through a series of interactive roundtables, panel discussions and 1:1 meetings.
Scott Davis, Sr. Director, Therapeutic Science and Strategy, Quintiles will facilitate the following roundtable session:
Operational strategies for executing complex multi-arm PhIB/II studies
Paul Berry, Global Senior Director, Scientific Support, Q² Solutions will facilitate the following roundtable session:
Ensure correct patient selection assays are utilized in the clinical trial